Acute Q fever related in-hospital mortality in the Netherlands

Netherlands Journal of Medicine

Volumn 68, Issue 12, 2010, Pages 408-413

  Kampschreur, L M ^a   Wegdam Blans, M C A ^b   Thijsen, S F T ^c   Groot, C A R ^d   Schneeberger, P M ^e   Hollander, A A M J ^e   Schijen, J H E M ^f   Arents, N L A ^b   Oosterheert, J J ^a   Wever, P C ^e  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b Stichting Laboratoria voor Pathologie en Medische Microbiologie   (Netherlands)

^c DEPARTMENT OF SURGERY   (Netherlands)

^d BERNHOVEN HOSPITAL   (Netherlands)

^e JEROEN BOSCH HOSPITAL   (Netherlands)

^f CPRLab   (Netherlands)

Author keywords

Coxiella burnetii; Hospitalisation; Mortality; Q fever

Indexed keywords

ACICLOVIR; AMOXICILLIN; C REACTIVE PROTEIN; CEFTAZIDIME; CEFUROXIME; CIPROFLOXACIN; CLAVULANIC ACID; COTRIMOXAZOLE; DOXYCYCLINE; FLUCLOXACILLIN; FLUCONAZOLE; MEROPENEM; MOXIFLOXACIN; PENICILLIN G; TOBRAMYCIN; VANCOMYCIN; VORICONAZOLE;

ADULT; AGED; ARTICLE; CARDIOVASCULAR DISEASE; CLINICAL ARTICLE; CLINICAL FEATURE; COXIELLA BURNETII; DIABETES MELLITUS; FEMALE; HUMAN; LEUKOCYTE COUNT; LUNG DISEASE; MALE; MORTALITY; NETHERLANDS; NONHUMAN; Q FEVER; THORAX RADIOGRAPHY;

ACUTE DISEASE; AGED; AGED, 80 AND OVER; CHRONIC DISEASE; COMORBIDITY; DISEASE OUTBREAKS; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MIDDLE AGED; NETHERLANDS; Q FEVER; RISK FACTORS;

EID: 78651474379     PISSN: 03002977     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Hartzell JD, Wood-Morris RN, Martinez LJ, Trotta RF. Q Fever: epidemiology, diagnosis and Treatment. Mayo Clin Proc. 2008;83(5):574-9.
2. Tissot-Dupont H, Raoult D. Q fever. Infect Dis Clin N Am. 2008;22:505-14.
3. Parker NR, Bararlet JH, Morton Bell A. Q Fever. Lancet. 2006;367:679-88.
4. Cutler SJ, Bouzid M, Cutler RR. Q Fever. J Infect. 2007;54:313-8.
5. Raoult D, Marrie TJ, Mege JL. Natural history and pathophysiology of Q Fever. Lancet. 2005;5:219-26.
6. Pentilla IA, Harris RJ, Storm P, Haynes D, Worswick DA, Marmion BP. Cytokine dysregulation in the post-Q-fever fatigue syndrome. Q J Med. 1998;91:549-60.
7. Limonard GJM, Peters JB, Nabuurs-Franssen MH, et al. Detailed analysis of health status of Q fever patients 1 year after the first Dutch outbreak: a case-control study. Q J Med. 2010;[Epub ahead of print].
8. Brouqui P, Tissot-Dupont H, Drancourt M, et al. Chronic Q fever. Ninety-two cases from France, including 27 cases without endocarditis. Arch Intern Med. 1993;153:642-8.
9. van der Hoek W, Dijkstra F, Schimmer B, Schneeberger PM, Vellema P, Wijkmans C, et al. Q fever in the Netherlands: an update on the epidemiology and control measures. Euro Surveill. 2010;15(12): pii=19520.
10. Q fever-United Kingdom (2nd ed.), MMWR 28 (1979), p. 230.
11. Tissont-Dupont H, Raoult D, Brouqui P,et al. Epidemiologic features and clinical presentation of acute Q fever in hospitalized patients: 323 French cases. Am J Med. 1992;93:427-34.
12. Fournier P, Marrie TJ, Raoult D. Diagnosis of Q fever. J Clin Microbiol. 1998:1823-34.
13. Schneeberger PM., Hermans MH, van Hannen EJ, Schellekens JJ, Leenders AC, Wever PC. Real-time PCR with serum samples is indispensable for early diagnosis of acute Q fever. Clin Vaccine Immunol. 2010;17:286-90.
14. Wegdam-Blans MCA, Nabuurs-Franssen MH, Horrevorts AM, Peeters MF, Schneebergen PM, Bijlmer HA. Labarotoriumdiagnostiek van acute Q-koorts. Ned Tijdschr Geneeskd. 2010;154:A2388.
15. Lim WS, van der Eerden MM, Laing R, et al. Defining community acquired pneumonia severity on presentation to hospital: an international derivation and validation study. Thorax. 2003;58:377-82.
16. Bruns AHW, Oosterheert JJ, Cucciolillo MC, el Moussaoui R, Prins JM, Hoepelman AIM. High mortality rates due to co-morbidity after recovery from community-acquired pneumonia. Abstract no. L1-998 presented on ICAAC 2009, San Francisco.
17. de Wit NC, de Jager CP, Meekelenkamp JC, et al. Markers of infection in inpatients and outpatients with acute Q fever. Clin Chem Lab Med. 2009;47(11):1407-9.